Godsey & Gibb’s Bristol-Myers Squibb Rights CELG.RT Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG.RT
Godsey & Gibb's CELG.RT Position: Q1 2021 in Review
Godsey & Gibb sold out of Bristol-Myers Squibb Rights (CELG.RT) in Q1 2021, closing a stake of 19,000 shares — an estimated $7K sold.
Godsey & Gibb first reported a position in CELG.RT in Q2 2020 and held it in 3 quarters. The position peaked at $8K in Q2 2020. 20 funds tracked by Wall St. Rank hold CELG.RT as of Q1 2021.
- Godsey & Gibb reported no remaining Bristol-Myers Squibb Rights position as of Q1 2021 after selling out during the quarter.
- Godsey & Gibb sold 19,000 Bristol-Myers Squibb Rights shares in Q1 2021, an estimated $7K.
- Godsey & Gibb first reported a position in Bristol-Myers Squibb Rights in Q2 2020 and held it in 3 quarters.
- Godsey & Gibb's Bristol-Myers Squibb Rights position peaked at $8K in Q2 2020.
- 20 funds tracked by Wall St. Rank held Bristol-Myers Squibb Rights as of Q1 2021.
Based on Godsey & Gibb's 13F filing for Q1 2021, filed 13 May 2021.